Exploring Nature′s Pharmacy through Bioprospecting and Bio−Discovery of Natural Products

Tanima Castrignano^*
*Correspondence: Tanima Castrignano, Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy, Email:

Keywords

Bioprospecting • Bio-discovery • Natural products • Drug development • Biodiversity • Sustainable solutions

Introduction

Bioprospecting and bio-discovery involve the exploration and exploitation of biodiversity to identify valuable compounds that can be used for various purposes, including drug discovery, agriculture, and industrial applications. The rich diversity of organisms on our planet offers an extensive pool of natural products, which have played a crucial role in the development of numerous life-saving drugs. These compounds possess diverse chemical structures and bioactivities, making them attractive targets for research and development. Natural products have been a valuable source of lead compounds for drug discovery and development. Many well-known drugs, such as aspirin, morphine and paclitaxel, have been derived from natural sources. The structural complexity and diversity of natural products often provide a unique advantage in targeting complex disease mechanisms. Additionally, their evolutionary history suggests a potential for high affinity and selectivity for specific biological targets. Moreover, natural products frequently exhibit a wide range of biological activities, including antimicrobial, anticancer, antiinflammatory and immunomodulatory properties.

Bioprospecting and bio-discovery face several challenges, including the potential loss of biodiversity due to habitat destruction, climate change and overexploitation. Protecting and conserving natural habitats is crucial for maintaining a sustainable supply of valuable organisms and their potential bioactive compounds. Furthermore, the limited availability of samples and the complexity of isolating and characterizing active compounds pose significant obstacles. Screening large numbers of samples and identifying bioactive compounds with desirable properties can be time-consuming, labor-intensive and costly. The advancements in technology, such as high-throughput screening techniques, robotics and artificial intelligence are transforming the field of bioprospecting and bio-discovery. These innovations streamline the process of sample collection, compound isolation, and characterization, allowing for more efficient and cost-effective screening of natural products. Additionally, collaborations between researchers, conservationists, and indigenous communities are vital for sustainable bioprospecting efforts, ensuring equitable sharing of benefits and promoting biodiversity conservation [1].

Literature Review

Bioprospecting and bio-discovery of natural products continue to be a promising avenue for drug development and industrial applications. By exploring nature's pharmacy, researchers can uncover valuable compounds with immense therapeutic potential. However, it is essential to balance the need for scientific progress with the preservation of biodiversity and the fair distribution of benefits. Through continued advancements in technology and collaboration, the future of bioprospecting and bio-discovery looks bright, holding promise for the development of innovative drugs and sustainable solutions. One area of great interest in bioprospecting and bio-discovery is the exploration of untapped and extreme environments [2]. Extremophiles, organisms that thrive in extreme conditions like high temperatures, high salinity or acidic environments, offer unique opportunities for discovering novel bioactive compounds. These extremophiles have developed exceptional adaptations to survive in their harsh habitats and the compounds they produce may have extraordinary properties. For example, enzymes isolated from extremophiles have been used in industrial processes due to their stability and functionality under extreme conditions.

In addition to extremophiles, marine organisms have gained considerable attention in bioprospecting. The world's oceans are home to a vast array of marine life, many of which produce bioactive compounds with remarkable potential. Marine organisms, such as sponges, corals and marine microbes have yielded compounds with anticancer, antiviral and neuroprotective activities. Marine-derived compounds, like the antiviral drug Ziconotide, have made significant contributions to the pharmaceutical industry. Genomics and metagenomics have revolutionized the field of bioprospecting by enabling researchers to explore the genetic potential of microorganisms. Metagenomics involves studying the collective genomes of microorganisms present in an environmental sample, providing insights into the diverse genetic repertoire of a habitat. This approach has led to the discovery of novel enzymes, antibiotics and other bioactive molecules. By harnessing the power of genomics, scientists can identify specific gene clusters responsible for the production of desired compounds, allowing for targeted efforts to produce these compounds in large quantities [3,4].

Discussion

The sustainable utilization of biodiversity and equitable sharing of benefits are crucial considerations in bioprospecting and bio-discovery. Collaborations with indigenous communities, who possess traditional knowledge about local flora and fauna are essential for responsible and ethical bioprospecting practices. Respecting the rights, knowledge and cultural heritage of indigenous peoples ensures a fair and equitable distribution of benefits derived from natural products. By engaging in mutually beneficial partnerships, researchers can obtain valuable insights from indigenous communities, leading to more effective and sustainable bioprospecting efforts. Furthermore, conservation of natural habitats and biodiversity is vital for the long-term success of bioprospecting. Rapid habitat loss, deforestation and climate change pose significant threats to the world's ecosystems, diminishing the potential for discovering new bioactive compounds. Conservation efforts, including protected areas and sustainable land management practices, are essential for preserving biodiversity hotspots and ensuring the continued availability of valuable organisms for research [5,6].

Conclusion

Bioprospecting and bio-discovery of natural products offer immense potential for the development of new drugs and sustainable solutions. Through the exploration of diverse environments, utilization of advanced technologies and collaborations with indigenous communities, researchers can unlock nature's pharmacy and uncover valuable bioactive compounds. However, it is crucial to balance scientific progress with the preservation of biodiversity and the fair distribution of benefits. By embracing responsible and ethical practices, the field of bioprospecting can continue to make significant contributions to human health and environmental sustainability in the years to come.

Acknowledgement

We thank the anonymous reviewers for their constructive criticisms of the manuscript.

Conflict of Interest

The author declares there is no conflict of interest associated with this manuscript.

References

1. Scherlach, Kirstin and Christian Hertweck. "Triggering cryptic natural product biosynthesis in microorganisms." Org Biomol Chem 7 (2009): 1753-1760.

Google Scholar, Crossref

2. Nitiss, John L. "DNA topoisomerase II and its growing repertoire of biological functions." Nat Rev Cancer 9 (2009): 327-337.

Google Scholar, Crossref, Indexed at

3. Wang, Yi, Xiaohui Fan, Haibin Qu and Xiumei Gao, et al. "Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine." Curr Top Med Chem 12 (2012): 1356-1362.

Google Scholar, Crossref, Indexed at

4. Bergsdorf, Christian and Johannes Ottl. "Affinity-based screening techniques: Their impact and benefit to increase the number of high quality leads." Expert Opin Drug Discov 5 (2010): 1095-1107.

Google Scholar, Crossref, Indexed at

5. Cooper, Matthew A. "Optical biosensors in drug discovery." Nat Rev Drug Discov 1 (2002): 515-528.

Google Scholar, Crossref, Indexed at

6. Singh, R. D., S. K. Mody, H. B. Patel and Sarita Devi, et al. "Antimicrobial drug discovery: Evident shifting from terrestrial to marine micro-organisms." Int J Curr Microbiol Appl Sci 6 (2017): 2322-2327.

Google Scholar, Crossref, Indexed at